Elixirgen Therapeutics, Inc.

CIK 1744333 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Elixirgen Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 13, 2025D0001744333-25-000004
Apr 9, 2025D0001744333-25-000002
Feb 12, 2025D0001744333-25-000001
Dec 1, 2023D0001744333-23-000001
Sep 29, 2022D0001744333-22-000001
Feb 18, 2021D0001744333-21-000003
Aug 17, 2020D/A0001744333-20-000001
Dec 2, 2019D0001744333-19-000001
Jun 25, 2018D0001744333-18-000001